NCT02901548 Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder Status TERMINATED Phase PHASE2
NCT02899949 Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin Status COMPLETED Phase N/A
NCT02899195 Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma Status COMPLETED Phase PHASE2
NCT02891161 Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder Status TERMINATED Phase PHASE1/PHASE2
NCT02889900 Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02882308 Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck. Status COMPLETED Phase PHASE2
NCT02879617 A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients Status COMPLETED Phase PHASE2
NCT02879318 Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT02879162 Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours Status COMPLETED Phase PHASE2
NCT02878252 Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and Taiwan Status COMPLETED Phase N/A
NCT02875834 A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia Status COMPLETED Phase PHASE3
NCT02870920 Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02869438 A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation Status COMPLETED Phase PHASE3
NCT02868632 Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1
NCT02866747 A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT02859129 Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) Status COMPLETED Phase PHASE1
NCT02856893 Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE) Status ACTIVE_NOT_RECRUITING Phase PHASE2